EASTLEIGH MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: J82020 | EASTLEIGH, SO50 9AG
Showing results 501-550 of 572
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 14 | 30 | £430 | +83.0% ▲ | |
| 14 | 70 | £139 | +18.7% ▲ | |
| Budesonide | 13 | 1,570 | £1.4K | -17.0% ▼ |
| Olmesartan medoxomil | 13 | 644 | £37 | -81.1% ▼ |
| Phenelzine sulfate | 13 | 728 | £875 | +26.9% ▲ |
| Modafinil | 13 | 1,128 | £75 | -37.7% ▼ |
| Acamprosate calcium | 13 | 1,806 | £202 | -62.7% ▼ |
| Avanafil | 13 | 104 | £349 | +107.1% ▲ |
| Sodium feredetate | 13 | 3,028 | £87 | -54.6% ▼ |
| Sodium zirconium cyclosilicate | 13 | 930 | £5.1K | +48.0% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 13 | 74.8K | £873 | -30.6% ▼ |
| Powder extensively hydrolysed formula with MCT (0913102) | 13 | 42.8K | £1.8K | +132.8% ▲ |
| Celecoxib | 13 | 780 | £31 | -80.3% ▼ |
| Emollient bath and shower preparations | 13 | 7,600 | £103 | -79.3% ▼ |
| Permethrin | 13 | 990 | £375 | -65.5% ▼ |
| 13 | 390 | £918 | +97.8% ▲ | |
| 13 | 116 | £464 | -67.0% ▼ | |
| 13 | 260 | £3.5K | +24.4% ▲ | |
| 13 | 6,500 | £56 | -85.7% ▼ | |
| 13 | 24 | £932 | +53.2% ▲ | |
| 13 | 390 | £215 | +25.9% ▲ | |
| 13 | 490 | £1.7K | +73.4% ▲ | |
| 13 | 450 | £2.7K | +13.0% ▲ | |
| Linaclotide | 12 | 644 | £821 | -34.3% ▼ |
| Telmisartan | 12 | 728 | £172 | -79.3% ▼ |
| Olmesartan medoxomil/hydrochlorothiazide | 12 | 448 | £232 | +21.0% ▲ |
| Glycopyrronium/formoterol | 12 | 13 | £402 | -52.6% ▼ |
| Brivaracetam | 12 | 896 | £2.1K | -64.7% ▼ |
| Fosfomycin trometamol | 12 | 13 | £60 | -57.8% ▼ |
| Diazoxide | 12 | 1,344 | £1.5K | +45.4% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 12 | 67.2K | £1.6K | +12.5% ▲ |
| Gentamicin sulfate | 12 | 120 | £228 | +118.4% ▲ |
| Azelastine hydrochloride | 12 | 96 | £73 | +1.0% vs avg |
| 12 | 130 | £376 | +90.2% ▲ | |
| 12 | 85 | £189 | -17.8% ▼ | |
| 12 | 192 | £875 | +194.7% ▲ | |
| 12 | 1,910 | £398 | -53.5% ▼ | |
| 12 | 360 | £1.3K | +56.9% ▲ | |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 11 | 812 | £337 | -32.7% ▼ |
| Methyldopa | 11 | 3,024 | £613 | -35.4% ▼ |
| Valsartan | 11 | 532 | £126 | -81.3% ▼ |
| Buspirone hydrochloride | 11 | 876 | £104 | -78.2% ▼ |
| Perampanel | 11 | 420 | £2.0K | -49.2% ▼ |
| Magnesium glycerophosphate | 11 | 2,340 | £994 | -19.9% ▼ |
| Other compound vitamin/mineral formulation preparations | 11 | 855 | £63 | -65.7% ▼ |
| Indometacin | 11 | 686 | £45 | -30.1% ▼ |
| Azelastine hydrochloride | 11 | 330 | £150 | -1.9% vs avg |
| Benzydamine hydrochloride | 11 | 2,490 | £55 | -85.8% ▼ |
| 11 | 120 | £86 | -66.0% ▼ | |
| 11 | 120 | £179 | -48.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.